AGLONEX

Brand name authorized in: Spain

Active ingredients

The drug AGLONEX contains one active pharmaceutical ingredient (API):

1 Agomelatine
UNII A17BS39YWR - AGOMELATINE CITRIC ACID

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset.

Read about Agomelatine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Agomelatine
N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX22

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
ES
Centro de informaciĆ³n online de medicamentos de la AEMPS
Identifier(s): 83440